C erebral arterial pulsatility is associated with white matter hyperintensities 1 and cognitive decline 2 and is largely determined by central arterial pulsatility and arterial stiffness. 1 No therapies have been specifically developed to affect cerebral arterial pulsatility, but such effects may explain the greater reduction in stroke risk with calcium channel blockers than β-blockers, despite similar blood pressure (BP) reductions. 3,4 Cerebral arterial pulsatility is usually measured by transcranial Doppler, 5 with good temporal but limited spatial resolution, whereas current magnetic resonance imaging (MRI) sequences have good spatial but limited temporal resolution. Furthermore, there are practical difficulties in continuous BP measurement during MRI. We piloted a novel method of continuous BP measurement during high temporal resolution MRI (multiband-blood-oxygen level dependent imaging [MB-BOLD]) 6,7 and determined its potential utility by assessing transmission of arterial pulsations on amlodipine versus propranolol.
C erebral arterial pulsatility is associated with white matter hyperintensities 1 and cognitive decline 2 and is largely determined by central arterial pulsatility and arterial stiffness. 1 No therapies have been specifically developed to affect cerebral arterial pulsatility, but such effects may explain the greater reduction in stroke risk with calcium channel blockers than β-blockers, despite similar blood pressure (BP) reductions. 3, 4 Cerebral arterial pulsatility is usually measured by transcranial Doppler, 5 with good temporal but limited spatial resolution, whereas current magnetic resonance imaging (MRI) sequences have good spatial but limited temporal resolution. Furthermore, there are practical difficulties in continuous BP measurement during MRI. We piloted a novel method of continuous BP measurement during high temporal resolution MRI (multiband-blood-oxygen level dependent imaging [MB-BOLD]) 6, 7 and determined its potential utility by assessing transmission of arterial pulsations on amlodipine versus propranolol.
Methods
Ten healthy adult subjects were randomized (according to CAMARADES recommendations for nonclinical studies 8 ) to 1 week of daily amlodipine 10 mg or propranolol-LA 160 mg in a crossover design, with a 2-week washout. This physiological protocol was assessed by the Medicines and Healthcare products Regulatory Authority. At baseline and on each drug, carotid-femoral pulse wave velocity and aortic BP (Sphygmocor) were measured. 1 Transcranial Doppler ultrasound (DWL-Doppler Box) was performed with a handheld 2 MHz probe on the same side as carotid applanation, at 50 mm or at the depth of the optimal waveform. Gosling's pulsatility index (middle cerebral artery-pulsatility index, MCA-PI=(systolic cerebral blood flow velocity-diastolic cerebral blood flow velocity)/ mean cerebral blood flow velocity) and MCA transit time were calculated. 1 All waveforms were visually inspected. On a 3T Siemens Verio scanner, a volume-acquisition T1 multiplanar reconstruction (1.5×1.5×1.5 mm voxels) and a 12-minute multiband BOLD-MRI (multiband factor=6, 30 slices, 3×3×3 mm voxels, echo time=40 ms, repetition time=0.43 s; Figure I in the online-only Data Supplement) 6, 7 were acquired. Continuous, noninvasive brachial
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BP was simultaneously acquired by a novel method ( Figure 1 9 ), and then the MNI-152 brain for group analysis (FNIRT-FSL 9 ). Nonphysiological artefactual components were identified and removed manually by independent component analysis. 9 Voxelto-voxel differences in pulse arrival time were measured by eventrelated summation of each time series to the peripheral BP marker (Figure 2 ), phase shifting voxels by differences in peak arrival time with interpolation by piecewise cubic hermitte interpolation.
For each voxel, power spectra (Welch, 350 volume segments, 50% overlap, nfft 512 volumes) and mean-squared coherence with BP were derived. Correlation between cardiac frequency BP and BOLD signal was determined on each treatment and compared between treatments (FSL-FEAT).
Results
Of 5 men and 5 women (median age=29, range=18-41) recruited, all completed the protocol, half receiving amlodipine first. Both drugs reduced aortic BP, pulsatility and pulse wave velocity, and cerebral blood flow velocity similarly (Table) , although MCA-PI increased nonsignificantly more with propranolol.
The coherence (frequency-specific relationship) between the BOLD signal and the peripheral BP at the cardiac cycle frequency was greatest in the ventricles and venous sinuses, but was also present throughout gray matter. Averaging BOLD responses for each voxel across all cardiac cycles produced identifiable arterial waveforms ( Figure 1 ). The peripheral cardiac cycle frequency BP waveform was more strongly associated with BOLD signal in gray matter on propranolol than amlodipine ( Figure 2 ). This was unchanged when excluding individual subjects from the analysis.
Discussion
We simultaneously acquired noninvasive, continuous BP and high-frequency BOLD MRI, demonstrating a direct relationship at the frequency of the cardiac cycle. This relationship was stronger on propranolol than amlodipine, despite similar effects on aortic BP and pulsatility.
Cerebral artery pulsatility is associated with chronic white matter disease, 1, 3 potentially because of increased transmission of aortic pulsatility to the brain through stiff vessels. 1 However, investigation of dynamic cerebral blood flow changes is limited by poor temporal resolution of standard MRI sequences, low spatial resolution of transcranial Doppler, and practical difficulties in continuous BP measurement during MRI scanning. We used a recently developed high-frequency MRI sequence 6, 7 and developed a novel method of concurrent, continuous BP monitoring. With refinement, this technique could allow detailed assessment of transmission of rapid fluctuations in systemic BP on region-specific cerebral blood flow. Indeed, we found a stronger association with the cardiac cycle waveform on propranolol than on amlodipine. This may reflect less dampening of systemic BP which could expose the brain to greater arterial pulsatility. This is a potential explanation for differences in cerebrovascular physiology and stroke risk between the 2 drugs 4,5,10 that warrants further investigation.
Our study has several limitations. First, subjects were healthy volunteers with less arteriopathy than more elderly patients at a greater risk of stroke. As such, the effects of drugs in this study cannot be extrapolated to clinical populations. Second, BOLD is affected by blood flow, blood oxygenation, and blood volume. However, the associations we demonstrated with cardiac frequency BP variation reflect BOLD variation at a higher frequency than neurovascular coupling and is therefore likely to be dependent primarily on blood flow. Third, the BP measurement method is susceptible to artefactual slow drifts in BP, which were filtered out offline. This has minimal impact on the high-frequency BP fluctuations we addressed, but limits the technique for investigating slower fluctuations in BP. Fourth, the stronger association between cardiac cycle frequency BP fluctuations and the BOLD signal on propranolol superficially follows a different pattern to the distribution of greatest cerebral pulsation, likely reflecting highest absolute brain perfusion in the gray matter and limiting the sensitivity of the analysis for effects on white matter perfusion. This may reflect correlations between BP and BOLD not directly dependent on the magnitude of BP pulsatility, but this pattern of cerebral pulsation has also been demonstrated using a surrogate of peripheral BP. 11 Finally, given a repetition time=0.43, heart rates above 70 bpm result in aliasing of the cardiac pulsation. Only one subject had an excess mean resting heart rate, and excluding this individual did not alter the results (data not shown). However, in a broader population, multiband imaging with a shorter TR 11 would limit aliasing. We piloted a novel method of concurrent, continuous noninvasive BP measurement during high-frequency BOLD MRI to assess transmission of arterial pulsatility to the brain, demonstrating a stronger association on propranolol than amlodipine. This needs further development but with refinement could enable systematic MRI-based assessment of rapid BP fluctuations effects on the cerebral circulation.
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